ZTS · Zoetis Inc.
$75.37
+0.80 (+1.07%)
At close · Jul 24
Market Cap
$31.59B
Shares
419.23M
Zoetis Inc. Earnings Call Transcripts
Every quarterly earnings call for Zoetis Inc. (ZTS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲0.6%
$2.00B
$529.00M
'22 Q3
22-11-03
▲3.7%
$2.04B
$461.00M
'22 Q4
23-02-14
▲0.7%
$2.00B
$552.00M
'23 Q1
23-05-04
▲6.2%
$2.18B
$671.00M
'23 Q2
23-08-08
▲7.4%
$2.15B
$596.00M
'23 Q3
23-11-02
▲8.5%
$2.21B
$525.00M
'23 Q4
24-02-13
▲9.5%
$2.19B
$599.00M
'24 Q1
24-05-02
▲8.3%
$2.36B
$624.00M
'24 Q2
24-08-06
▲11%
$2.39B
$682.00M
'24 Q3
24-11-04
▲4.7%
$2.32B
$581.00M
'24 Q4
25-02-13
▲0.4%
$2.20B
$602.00M
'25 Q1
25-05-06
▲4.2%
$2.46B
$718.00M
'25 Q2
25-08-05
▲0.5%
$2.40B
$721.00M
'25 Q3
25-12-02
▲4%
$2.41B
$632.00M
'25 Q4
26-02-12
LATEST
▲2.9%
$2.26B
$601.00M
'26 Q1
26-05-07
Earnings call
FY26 · Q2
2026-08-06
Zoetis to Host Webcast and Conference Call on Second Quarter 2026 Financial Results
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-02
William Blair 46th Annual Growth Stock Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-28
Stifel 2026 Jaws and Paws Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Zoetis Inc. Q1 FY2026 Earnings Call
Cautious tone
Competitive intensity
Companion animal pressure
OA Pain / Librela
Revenue
$2.26B
▲ 2.9% YoY Diluted EPS
$1.42
▲ 6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-10
Barclays 28th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-03-09
Leerink Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-12
Zoetis Inc. Q4 FY2025 Earnings Call
Positive tone
Livestock and international growth
Simparica / Trio franchise
2026 financial guidance
Revenue
$2.41B*
▲ 4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-01-12
44th Annual J.P. Morgan Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-12-02
Zoetis Inc. Q3 FY2025 Earnings Call
Positive tone
OA pain franchise (Librela/Solensia/Lenivia/Portela)
Innovation pipeline and approvals
Parasiticides franchise (Simparica/Trio)
Revenue
$2.40B
▲ 0.5% YoY Diluted EPS
$1.63
▲ 8.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Zoetis Inc. Q2 FY2025 Earnings Call
Confident tone
International and geographic growth
Companion Animal franchise momentum
Librela / OA Pain adoption challenges
Revenue
$2.46B
▲ 4.2% YoY Diluted EPS
$1.61
▲ 17.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Zoetis Inc. Q1 FY2025 Earnings Call
Confident tone
Companion animal growth (Simparica, dermatology, OA pain)
Librela / OA pain adoption ramp
Tariffs and pharmaceutical policy (Section 232)
Revenue
$2.20B
▲ 0.4% YoY Diluted EPS
$1.34
▲ 2.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
Zoetis Inc. Q4 FY2024 Earnings Call
Confident tone
Companion animal growth and key franchises
Osteoarthritis pain franchise (Librela/Solensia)
2025 financial guidance and outlook
Revenue
$2.32B*
▲ 4.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Zoetis Inc. Q3 FY2024 Earnings Call
Confident tone
Librela/Solensia (OA pain franchise)
Dermatology franchise (Apoquel/Cytopoint)
Simparica Trio (parasiticides)
Revenue
$2.39B
▲ 11% YoY Diluted EPS
$1.50
▲ 16.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Zoetis Inc. Q2 FY2024 Earnings Call
Confident tone
Dermatology franchise (Apoquel/Cytopoint)
Companion animal innovation (Librela/Solensia)
Livestock portfolio
Revenue
$2.36B
▲ 8.3% YoY Diluted EPS
$1.37
▼ 5.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Zoetis Inc. Q1 FY2024 Earnings Call
Confident tone
Companion animal / OA pain franchise (Librela, Solensia)
Librela safety / FDA and vet engagement
Parasiticides (Simparica, Simparica Trio)
Revenue
$2.19B
▲ 9.5% YoY Diluted EPS
$1.31
▲ 10.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-13
Zoetis Inc. Q4 FY2023 Earnings Call
Confident tone
Librela / Solensia (OA pain monoclonal antibodies)
2024 financial guidance and outlook
Companion animal portfolio
Revenue
$2.21B*
▲ 8.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Zoetis Inc. Q3 FY2023 Earnings Call
Revenue
$2.15B
▲ 7.4% YoY Diluted EPS
$1.29
▲ 14.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Zoetis Inc. Q2 FY2023 Earnings Call
Revenue
$2.18B
▲ 6.2% YoY Diluted EPS
$1.45
▲ 29.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Zoetis Inc. Q1 FY2023 Earnings Call
Revenue
$2.00B
▲ 0.7% YoY Diluted EPS
$1.19
▼ 5.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-14
Zoetis Inc. Q4 FY2022 Earnings Call
Revenue
$2.04B*
▲ 3.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Zoetis Inc. Q3 FY2022 Earnings Call
Revenue
$2.00B
▲ 0.6% YoY Diluted EPS
$1.13
▼ 2.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Zoetis Inc. Q2 FY2022 Earnings Call
Revenue
$2.05B
▲ 5.3% YoY Diluted EPS
$1.12
▲ 4.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Zoetis Inc. Q1 FY2022 Earnings Call
Revenue
$1.99B
▲ 6.1% YoY Diluted EPS
$1.26
▲ 7.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-15
Zoetis Inc. Q4 FY2021 Earnings Call
Revenue
$1.97B*
▲ 8.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Zoetis Inc. Q3 FY2021 Earnings Call
Revenue
$1.99B
▲ 11.4% YoY Diluted EPS
$1.16
▲ 16% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Zoetis Inc. Q2 FY2021 Earnings Call
Revenue
$1.95B
▲ 25.8% YoY Diluted EPS
$1.07
▲ 35.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Zoetis Inc. Q1 FY2021 Earnings Call
Revenue
$1.87B
▲ 22% YoY Diluted EPS
$1.17
▲ 33% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-16
Zoetis Inc. Q4 FY2020 Earnings Call
Revenue
$1.81B*
▲ 7.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Zoetis Inc. Q3 FY2020 Earnings Call
Revenue
$1.79B
▲ 12.8% YoY Diluted EPS
$1.00
▲ 11.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Zoetis Inc. Q2 FY2020 Earnings Call
Revenue
$1.55B
▲ 0.1% YoY Diluted EPS
$0.79
▲ 2.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Zoetis Inc. Q1 FY2020 Earnings Call
Revenue
$1.53B
▲ 5.4% YoY Diluted EPS
$0.88
▲ 35.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Zoetis Inc. Q4 FY2019 Earnings Call
Revenue
$1.67B
▲ 7% YoY Diluted EPS
$0.80
▲ 12.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–32 of 32 earnings calls
Key facts
CIK
1555280
CUSIP
98978V103
13F (30d)
386 filings
382 filers
Visit website
Investor relations